Efficacy of Brexpiprazole in Participants with Agitation Associated with Dementia Due to Alzheimer’s Disease: Pooled Analysis of Randomized Controlled Trials

Key Points

• Brexpiprazole shows a significant reduction in agitation associated with dementia.
• In pooled analyses of trials, participants demonstrated improved scores for agitation symptoms.
• This analysis involved a comprehensive review of randomized controlled trials focused on Alzheimer's-related agitation.
• Findings suggest brexpiprazole may enable better management strategies for agitation in dementia patients.